StratDeck

Two stocks in Healthcare

Novartis vs Ypsomed Holding: profit, growth, debt and price compared

Ypsomed Holding is stronger on 4 of 7 figures: profit margin, debt, analysts' view and price trend. Novartis is stronger on 3: sales growth, price for its expected profit and dividend.

Figures as of 18 November 2026Yahoo Finance
Explore Novartis' storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Novartis and Ypsomed Holding side by side
NovartisNOVN.SWYpsomed HoldingYPSN.SW
Net margin17.5%Stronger: 30.4%
Revenue growth, past yearStronger: +4.70%−13.30%
Debt to equity128.6%Stronger: 34.9%
Forward P/EStronger: 15.9×28.8×
Dividend yieldStronger: 2.78%1.04%
AnalystsHold · 22Stronger: Buy · 14
From its 200-day average+9.2%Stronger: +21.2%

Share price over the past year

  • Novartis+24.3%
  • Ypsomed Holding+34.1%

17 Nov 202518 Nov 2026

Novartis or Ypsomed Holding: which is stronger?

  • YPSN.SW

    Which is more profitable?

    Ypsomed Holding keeps more of each sale as profit: 30.4% against 17.5%.

  • NOVN.SW

    Which is growing its sales faster?

    Novartis is growing its sales faster: +4.70% over the past year, against −13.30%.

  • YPSN.SW

    Which has borrowed less?

    Ypsomed Holding has borrowed less: its debt is 34.9% of what its shareholders own, against 128.6% for Novartis.

  • NOVN.SW

    Which costs less for the profit it is expected to make?

    Novartis costs less for the profit it is expected to make: 15.9× its forward earnings, against 28.8×.

  • NOVN.SW

    Which pays more in dividends?

    Novartis pays more back in dividends for what a share costs: 2.78% a year, against 1.04%.

  • YPSN.SW

    Which do analysts rate higher?

    Analysts are warmer on Ypsomed Holding: Buy, against Hold for Novartis.

  • YPSN.SW

    Which is in the stronger price trend?

    Ypsomed Holding's price is in the stronger trend: 21.2% above its 200-day average, against 9.2% above.

What each company does

NOVN.SWNovartis

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Reports results on 3 February 2027

YPSN.SWYpsomed Holding

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.

Reports results on 19 May 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.